News

JIC Venture Growth Investments has acquired the shares in Strand Therapeutics Inc. (Strand Therapeutics), through its JIC Venture Growth Fund 2 .

‍

Strand Therapeutics was founded in 2018 with the vision of “Powering the future of medicine” and aims to use synthetic biology to program mRNA and establish revolutionary therapies. Based on research at MIT and Kyoto University, Strand Therapeutics has built a proprietary mRNA programming language and will provide a drug discovery pipeline and platform business targeting cancer and immune cells.

‍

The purpose of VGI’s investment is to contribute to the realization of a healthy and long-lived society by providing innovative treatments to Japanese patients through social implementation of new modalities based on Japanese technology. On top of that, VGI also aims to strengthen the startup ecosystem by encouraging Japanese entrepreneurs overseas.

‍

VGI would like to support Strand Therapeutics to accelerate the research and development and contribute to the revitalization of the venture ecosystem.

‍

_{* mRNA is a single-stranded ribonucleic acid (RNA) molecule that is read during the process of protein synthesis. Vaccines have been implemented and are expected to be applied in the treatment of cancer and other diseases in the future.}

_{The information contained in this notice is current at the time of publication and subject to change without notice.}